1PeuraDA. Stress-related mucosal damage [J]. C lin Ther.1986; 8 Suppl A: 14.
2Wolfe MM. Considerations for selection of parenteral histmine(H2) - receptor antagonists [J]. Am J Med. 1987 Dee 18;83 (6A): 82.
3Hemandez DE, Stanley DA, Melvin JA, et al. Involvement of brain dopamine systems on neurotensin- induced ptotection against stress gastric lesios [J]. Brain Res, 1986; 381:159.
4Arakawa T, Higuchi K, Fukuda T, et al. Prostaglandins in the stomach : an update [J]. J Clin Gastroenterol, 1998; 27(Supp 1) :51.
5Suzuki H, Miura S, Imaeda H. Enlmnced levels of chemilu-minescence and platelet activating factor in unease positive gas-tric ulcers [J]. Free Radoc Biol Med, 1996; 20:449.
6Kinoshita M, Kume E, Tamaki H. Roles of prostaglandin,nitric oxide and the capsaiein-sensitive sensory reaves in gas-troprotection produced by ecabet sodium [J]. J. Pharmacol Exp Ther, 1996; 274 (1): 494.
7Flarmery J, Tucker DA. Pharmacologic prophylaxis and treat-merit of stress ulcers in critically ill patients [J]. Crit Care Nuts Clin North Am, 2002; 14 (1)- 39.
8Jung R, MacLaren R. Proton-pump inbibitors for stress ul-cer prophylaxis in critically ill patieats [J]. Ann Pharmacoth-er, 2002; 36 (12): 1929.
9Van Der Voort PH, Zandstra DF. J Pathogemsis, risk fac-tom, and incide nce of upper gastminmstinal blaming after cardiac surgery: is specific prophylaxis in routine bypass Pro-cedures needed [ J ]. Cardiothorac Vasc Anesth 2000; 14(3): 293.
10I Devlin JW, Claire KS, Dulclmvaky SA, etal. Impact of trauroa stress ulcer prophylaxis guidelines on drug cost and fre-quency of major gastrointestinal bleeding [J]. Pharmacothera-py 1999; 19 (4) : 452.
